Best Treatment for Barrett’s is Surgery

Slides:



Advertisements
Similar presentations
A 50-year-old man with a history of symptomatic gastroesophageal reflux disease (GERD) has Barrett’s esophagus diagnosed on upper endoscopy. Which of.
Advertisements

Bile Reflux and Bilitec System
Cancer of the GI System. Esophageal cancer Pathogenesis: Rare Secondary to infiltration/structure alteration Most common at gastroesophageal junction.
ESOFAGO DI BARRETT TERAPIA MEDICA & ENDOSCOPICA Massimo Conio Sanremo Massimo Conio Sanremo.
Post-operative Radiotherapy for Esophageal Cancer Parag Sanghvi, M.D., M.S.P.H. Department of Radiation Medicine Esophageal Care Conference 3/26/2007.
Carcinoma of the Cardia: Is there progress in the management of non-Barrett’s cancer Spanish Association of Surgeons Madrid 11 November 2002 The University.
DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.
Endoscopic Mucosal Resection (EMR)
Luigi Bonavina,MD Cattedra e U.O. Chirurgia Generale, Policlinico San Donato Università degli Studi di Milano XXIV Congresso Nazionale A.C.O.I. Montecatini.
Management of Barrett ’ s Esophagus Joint Hospital Surgical Grand Ground 17 th July 2010 Dr KS Chan Queen Elizabeth Hospital.
Laparoscopic Fundoplication and Barrett’s Carlos A. Pellegrini University of Washington Seattle, WA GI Cancer Course Saint Louis University.
 DISCUSSION Number of resected lymph nodes in esophageal surgery has been previously discussed as for its probable impact on patients’ survival [4]. The.
GENERAL THORACIC SURGERY CHAPTER 141
WILLIAM J. SALYERS, JR., MD, MPH DIVISION CHIEF/MEDICAL DIRECTOR KU WICHITA GASTROENTEROLOGY ASSOCIATE PROGRAM DIRECTOR INTERNAL MEDICINE RESIDENCY Putting.
ANDREW NG PRINCE OF WALES HOSPITAL Role of primary chemoradiation in esophageal carcinoma.
Barrett’s Esophagus Stuart Jon Spechler, M.D. Chief of Gastroenterology, Dallas VA Medical Center; Professor of Medicine, Berta M. and Cecil O. Patterson.
Gastrointestinal Diseases and Disorders Karen E. Hall, M.D., Ph.D. GRECC, Ann Arbor VA Health System University of Michigan Health System Contributors.
Radiofrequency Ablation of Lung Cancer
Gastro-esophageal Reflux Surgical Management Fahad Y. Bamehriz, MBBS, SBIS.
Endoscopic Treatment of Barrett’s Esophagus and Early Esophageal Cancer CTOP Retreat 2014 Dartmouth-Hitchcock Medical Center.
1 The Chemoprevention of Sporadic Colorectal Cancer Issues Surrounding a Benefit/Risk Analysis in Clinical Trials Mark Avigan MD CM Medical Officer Division.
Management of Barrett’s oEsophagus
HOW TO CONTROL CANCER Putting Science into Practice.
Upper GI Disease Where we are Dr Gary Mackenzie Consultant Gastroenterologist.
Other treatments for GERD… Lee L Swanstrom MD, FACS Division of Minimally Invasive Surgery Legacy Health System Portland, OR.
Barrett’s Esophagus SLR Grand Rounds May 30, 2007.
Esophageal Problems after Gastric Banding
Hiatal Hernia Repair, Vagotomy, Gastrectomy for GERD
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Gastroenterology Grand Rounds February 20, 2014 Fellow: David Tang, M.D. Faculty: Marcelo Vela, M.D.
Best Treatment for Barrett's esophagus is Medical George Triadafilopoulos, MD Clinical Professor of Medicine Stanford University School of Medicine M.I.S.S.,
Current Status of PDT in Gastroenterology 2015: Esophageal Carcinoma & Cholangiocarcinoma Herbert C. Wolfsen Mayo Clinic, Jacksonville, Florida.
Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.
Radiofrequency Ablation for Barrett’s Esophagus with HGD Gregory G. Ginsberg, M.D. Professor of Medicine University of Pennsylvania School of Medicine.
The ulcer of gastric stump: a case-control study Coordinators: Author: Roxana Spac Dr.Anca Negovan Drd. Monica Pantea Co-author: Dr Nina Sincu Andreea.
 Gastro-Oesophageal Reflux Disorder ● Present in around 10% of the population ● Symptoms or damage to the mucosal lining of the distal oesophagus ● Caused.
Minimally Invasive Esophagectomy Dmitry Oleynikov M.D. Associate Professor of Surgery Joseph and Richard Still Faculty Fellow in Medicine Director of Minimally.
General Principles Of Treatment. Treatment Goals To relieve the symptoms of Benign (Peptic Stricture) To improve patient’s nutritional status.
The Effect of Obesity on the Radicality of Subtotal Oesophagectomy for Oesophageal Adenocarcinoma S Wahed, HV Jones, A Krishnan, J Shenfine, SM Griffin.
Gastrointestinal Diseases Dr. Maha Arafah Pathology, 2012.
Update on Achalasia – Techniques and Outcomes William O. Richards MD, FACS Professor and Chair Department of Surgery and the Division of Gastrointestinal/Oncologic.
1 PHOTOFRIN® PDT for High-grade Dysplasia in Barrett’s Esophagus Edvardas Kaminskas, M.D. Medical Officer, CDER, ODE III, DGCDP Milton Fan, Ph.D. Statistical.
The Role of Secondary Versus Tertiary Prevention in Decreasing the Incidence of Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus Lindsay.
Collis Nissen for the Short Esophagus Collis Nissen for the Short Esophagus Bill Richards, MD, FACS Professor and Chair Surgery Bill Richards, MD, FACS.
DISEASES OF THE OESOPHAGUS BY Dr. ARWA M FUZI Lecture 1.
Treatment of GERD in Obese Patients David W Rattner, MD.
CT Colonography vs Colonoscopy for the Detection of Advanced Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K.
Lenalidomide Maintenance After Stem-Cell Transplantation for Multiple Myeloma: Follow-Up Analysis of the IFM Trial Attal M et al. Proc ASH 2013;Abstract.
Endoluminal Treatment of Barrett’s and Early Cancer Brant K. Oelschlager, MD University of Washington.
Important questions As good or better ? Cost effective ? Overall, safer? Is it safe as a cancer operation? Can all surgeons do it? Compare to open surgery.
Gastroesophageal Reflux Disease (GERD). * Definition: inflammation of the lower part of the esophagus due to abnormal reflux of gastric contents into.
Barrett’s Esophagus Dr. Robert Osterhoff, MD
Prof KHALED HEMIDA Ain Shams University. قال الله تعالي : يرفع الله الذين آمنوا منكم و الذين أوتوا العلم درجات. قال رسول الله ( صلي الله عليه و سلم ):
Eradication of Helicobacter pylori After Endoscopic Resection of Gastric Tumors Does Not Reduce Incidence of Metachronous Gastric Carcinoma Clinical Gastroenterology.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors F Zerbib, A Duriez, S Roman, M.
Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrett’s Esophagus Ganapathy A. Prasad, M.D. Navtej S. Buttar,
Bob Etemad, MD Medical Director of Endoscopy Main Line Health System.
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Volume 120, Issue 7, Pages (June 2001)
Bristol Royal Infirmary M.Boal, D. Titcomb 2/2/17
M.Boal; J. Batt; P. Wilkerson; D.R. Titcomb
Contribution by: Prof. Dr. J.J. Kolkman
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Barrett's esophagus: diagnosis and management
Endoscopic eradication therapy for patients with Barrett’s esophagus–associated dysplasia and intramucosal cancer  Sachin Wani, MD, Bashar Qumseya, MD,
Volume 120, Issue 7, Pages (June 2001)
Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma  Jörg Zehetner, MD, Steven R. DeMeester,
Barrett's esophagus: diagnosis and management
Presentation transcript:

Best Treatment for Barrett’s is Surgery Bill Richards, MD FACS Professor and Chair Surgery University of South Alabama College of Medicine

Barrett’s = Intestinal Metaplasia Metaplasia = change in cell-type Squamous to specialized intestinal cells First described by Norman Barrett in 1950 Adaptive mechanism to injury

Metaplasia (no dysplasia) Disease Course Progression usually occurs but regression sometimes seen Duration of progression variable Metaplasia (no dysplasia) Low-Grade Dysplasia High-Grade Dysplasia Adenocarcinoma Ginsberg et al. In: Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. 7th ed. 2002:647-671.

Risk of Adenocarcinoma in Barrett’s Esophagus 0.4-0.5% per year 5-10% lifetime

Current Management of Barrett’s Patients* Intestinal Metaplasia Surveillance (2-3 yrs) Low grade dysplasia Surveillance (6-12 mo) High grade dysplasia Surveillance (3 mo) vs. Esophagectomy This is how patients are managed right now - Watch and Wait Most patients are just watched As patient progresses to Low Grade Dysplasia, keep watching But once the dysplasia goes to High Grade, the choices have become very limited: Maybe Photodynamic Therapy or Esophagectomy Patients have to make a choice, They can be watched more often, or have the esophagus taken out. Then, if the diagnosis progresses to adenocarcinoma, the only choice is to take the esophagus out. Adenocarcinoma Esophagectomy vs. Palliative Care * May Differ per Institution

One Outcome of Surveillance Esophageal Adenocarcinoma Baseline Barrett’s Esophagus

Mixed Reflux of Gastric and Duodenal Juices is more Harmful to the Esophagus than Gastric Juice Alone Kauer WK et al Ann Surg 222: 525-533 Prevalence of esophageal bilirubin exposure

Bile Reflux Induces Adenocarcinoma of the Esophagus Ireland et al Ann Surg. 1996 September; 224(3): 358–371.

Antireflux Surgery 1976 Donahue and Bombeck defined a technique of "floppy" Nissen fundoplication (FNF) that prevented experimental pathologic reflux without preventing gaseous eructations or vomiting (normal reflux) when appropriate

LES Pressure Returns to Normal After Laparoscopic Fundoplication Peters JH et al. Ann Surg 1998;228:40-50.

24 Hour pH Studies after Laparoscopic Fundoplication Author # patients pH Negative Follow-up (months) Hinder (87%) 3-12 Hunter (91%) 12 Watson 3 Peters (93%) 21

Does Nissen reduce NonAcid Reflux? 8 patients with Barrett’s 24 hour pH and nonacid relfux - before (on omeprazole 20 mg BID) - after laparoscopic Nissen fundoplication

Acid Episodes Data are shown as median (horizontal line), interquartile range (box), and 5th to 95th percentile (vertical line)

P=0.001 Non-Acid Episodes Data are shown as median (horizontal line), interquartile range (box), and 5th to 95th percentile (vertical line)

Conclusions: Patients with Barrett’s esophagus Nissen eliminates acid and non-acid reflux PPI’s fail to eliminate acid reflux in 33-50% PPI’s do not reduce non-acid reflux

Ortiz et al Br J Surg. 1996 Feb;83(2):274-8 Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study. Ortiz et al Br J Surg. 1996 Feb;83(2):274-8

Regression of Barrett’s after Fundoplication STUDY # PATIENTS short segment % REGRESSION U WASHINGTON Ann Surg. 2003 October; 238(4): 458–466 61 56% USC Ann Surg. 2001 October; 234(4): 532–539 26 14%

Should We Treat Barrett’s? Standard of care = removal of pre-cancerous lesions colon polyps (7 M annual U.S. colonoscopies) cervical dysplasia breast masses dermatologic lesions (moles, actinic keratoses) In the rest of the medical world, we take out pre-cancerous lesions. But for Barrett’s esophagus, what do we do? Just watch and wait.

Techniques for Mucosal Ablation Mechanical Endoscopic mucosal resection (EMR) Photochemical Photodynamic Therapy Thermal Argon plasma coagulation Multi-polar coagulation Bipolar energy Lasers: Argon, Nd: YAG, KTP-YAG Low-flow cryoablation Techniques for Mucosal Ablation The methods of mucosal ablation can be divided into three basic categories. The mechanical is endoscopic mucosal resection which can usually is applied with cautery. It involves making sessile lesions in the esophagus more polypoid through either injection of a bulking agent such as saline, methylcellulose, or hypertonic glucose or applying suction to the lesion. Thermal methods cauterize a mucosal lesions and can involve multiple types of thermal energy including laser therapy. Photodynamic therapy is a combination therapy in which a photosensitizing drug must be given first to allow its accumulation within the mucosa. The drug can then be activated by light which produces the photodynamic effect which causes cell death.

Overall Conclusions Balloon-based ablation can eliminate all histological evidence of IM after 1-2 treatments No safety issues LGD and HGD trials underway Promising early results Early data shows complete elimination of dysplasia after one treatment as possible

Conclusion This is an exciting, rapidly growing field. Currently, there is no ideal ablative modality. Patients should be treated with very close followup. Multimodal ablative therapy may have significant role.

Summary Barrett’s associated with Non Acid and Acid Reflux Non acid and acid reflux can cause esophageal cancer in experimental animals

Summary Nissen significantly reduces acid and non acid reflux PPI’s reduce acid reflux only and normalize 50-80% of patients

Summary There is no proof that Nissen fundoplication can prevent progression to cancer. But Nissen fundoplication is the only modality that can reduce both acid and non acid reflux and has been shown to reverse Short Segment Barrett’s